Literature DB >> 15567449

Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.

Mehmet Birhan Yilmaz1, Yucel Balbay, Vedat Caldir, Selime Ayaz, Yesim Guray, Umit Guray, Sule Korkmaz.   

Abstract

BACKGROUND: Late venous graft thrombosis, leading to recurrent ischemia, is frequently encountered in old, degenerated vein grafts with advanced atherosclerotic plaque formation. Aspirin has been indicated to maintain venous graft patency in the post-operative period. However, there is considerable evidence that aspirin resistance is of concern in patients with venous grafts. MATERIAL AND
METHOD: Prospectively enrolled 14 patients (11 male, 3 female, Group 1), who were shown to have at least one occluded saphenous vein graft on their late control coronary angiogram after bypass operation, were compared for the presence of aspirin resistance by PFA-100 with age- and sex-matched 14 patients (10 male, 4 female, Group 2), who were found patent and well-functioning vein grafts without wall irregularities on late post-operative coronary angiograms (mean 6.5+/-2.5 years), enrolled as a control group.
RESULTS: Mean CT of collagen/epinephrine cartridge in Group 1 was 197+/-85 s and significantly less than in Group 2 (279+/-44 s; p=0.011). It was found that 50% of patients in Group 1 were so-called aspirin resistant, whereas in Group 2, this ratio was 7.1% (p=0.033). BMI (p=0.038, Beta=-0.322), uric acid level (p=0.023, Beta=-0.355), and CT by collagen/epinephrine cartridge (p=0.008, Beta=0.431) were independently predicting late occlusion of saphenous vein graft.
CONCLUSION: Aspirin resistance is highly prevalent in patients with occluded venous grafts at a relatively late period.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15567449     DOI: 10.1016/j.thromres.2004.07.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

1.  Acetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth noting.

Authors:  Michael R Buchanan
Journal:  Can J Cardiol       Date:  2007-03-01       Impact factor: 5.223

2.  Plateletcrit. A platelet marker associated with saphenous vein graft disease.

Authors:  I Akpinar; M R Sayin; Y C Gursoy; T Karabag; E Kucuk; M C Buyukuysal; M Aydin; I C Haznedaroglu
Journal:  Herz       Date:  2013-04-12       Impact factor: 1.443

3.  Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study.

Authors:  Jack C J Sun; Kevin H T Teoh; Tej Sheth; David Landry; Hyejung Jung; Theodore E Warkentin; Salim Yusuf; Andre Lamy; John W Eikelboom
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

4.  Aspirin resistance: Fact or fiction? A point of view.

Authors:  Jawahar L Mehta; Bhavna Mohandas
Journal:  World J Cardiol       Date:  2010-09-26

5.  Preoperative aspirin resistance does not increase myocardial injury during off-pump coronary artery bypass surgery.

Authors:  Hyun Joo Kim; Jung-Man Lee; Jeong Hwa Seo; Jun-Hyeon Kim; Deok-Man Hong; Jae-Hyon Bahk; Ki-Bong Kim; Yunseok Jeon
Journal:  J Korean Med Sci       Date:  2011-07-27       Impact factor: 2.153

Review 6.  Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis.

Authors:  Parvin Ebrahimi; Zeynab Farhadi; Masoud Behzadifar; Hosein Shabaninejad; Hassan Abolghasem Gorji; Masood Taheri Mirghaed; Morteza Salemi; Kamyar Amin; Roghayeh Mohammadibakhsh; Nicloa Luigi Bragazzi; Rahim Sohrabi
Journal:  Caspian J Intern Med       Date:  2020

7.  Effect of anti-platelet therapy on peri-operative blood loss in patients undergoing off-pump coronary artery bypass grafting.

Authors:  Samir Kapoor; Gurmeet Singh; Rajesh Chand Arya; Vikrampal Singh; Arun Garg; Sarju Ralhan; Vivek Kumar Gupta; Bishav Mohan; Gurpreet Singh Wander; Rajiv Kumar Gupta
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

8.  Frequency of development of aspirin resistance in the early postoperative period and inadequate inhibition of thromboxane A2 production after coronary artery bypass surgery.

Authors:  Hayrettin Özkan; İlker Kiriş; Şenol Gülmen; Hüseyin Okutan; Filiz Alkaya Solmaz; Kenan Abdurrahman Kara
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.